Lipids and Age-related Macular Degeneration

Survey of Ophthalmology

Volumn 56, Issue 3, 2011, Pages 195-213

  Kishan, Amar U ^a   Modjtahedi, Bobeck S ^b   Martins, Elisabeth N ^b,c   Modjtahedi, Sara P ^b   Morse, Lawrence S ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Age related macular degeneration; Cholesterol; Diet; Docosahexaenoic acid; Eicosapentaenoic acid; Human; Lipids; Metabolism; Omega 3; Statin

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; ASCORBIC ACID; BETA CAROTENE; DOCOSAHEXAENOIC ACID; ETANERCEPT; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; ICOSATETRAENOIC ACID; LINOLENIC ACID; LIPID; NEUROPROTECTIN D1; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; RESOLVIN D1; RESOLVIN E1; SIMVASTATIN; UNCLASSIFIED DRUG; ZINC;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR RISK; DIETARY INTAKE; DRUG EFFICACY; DRUG POTENTIATION; FAT INTAKE; FISH; GENE; GENE FUNCTION; HUMAN; IMMUNOREACTIVITY; LIPC GENE; LIPID METABOLISM; LIPID PEROXIDATION; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANIMALS; DIETARY FATS; HUMANS; LIPID METABOLISM; MACULAR DEGENERATION; RISK FACTORS;

EID: 79954630102     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2010.08.008     Document Type: Review

References (148)

1. Abalain J.H., Carre J.L., Leglise D., et al. Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels?. Clin Chim Acta 2002, 326(1-2):97-104.
2. Akanuma S., Yamamoto A., Okayasu S., et al. High-density lipoprotein-associated alpha-tocopherol uptake by human retinal pigment epithelial cells (ARPE-19 Cells): the irrelevance of scavenger receptor class B, type I. Biol Pharm Bull 2009, 32(6):1131-1134.
3. Anderson R.E., Maude M.B. Lipids of ocular tissues. 8. The effects of essential fatty acid deficiency on the phospholipids of the photoreceptor membranes of rat retina. Arch Biochem Biophys 1972, 151(1):270-276.
4. Arnarsson A., Sverrisson T., Stefansson E., et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 2006, 142(3):419-428.
5. Augood C., Chakravarthy U., Young I., et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr 2008, 88(2):398-406.
6. Baird P.N., Guida E., Chu D.T., et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004, 45(5):1311-1315.
7. Bazan N.G. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989, 312:95-112.
8. Bazan N.G. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids 2009, 81(2-3):205-211.
9. Beatty S., Koh H., Phil M., et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45(2):115-134.
10. Blumenkranz M.S., Russell S.R., Robey M.G., et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986, 93(5):552-558.
11. Bretillon L., Acar N., Seeliger M.W., et al. ApoB100, LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci 2008, 49(4):1307-1314.
12. Brown M.M., Brown G.C., Sharma S., et al. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol 2006, 17(3):257-266.
13. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl):1505S-1519S.
14. Catalá A. An overview of lipid peroxidation with emphasis in outer segments of photoreceptors and the chemiluminescence assay. Int J Biochem Cell Biol 2006, 38(9):1482-1495.
15. Chan C.C., Ross R.J., Shen D., et al. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res 2008, 40(3-4):124-128.
16. Chiu C.J., Klein R., Milton R.C., et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-related Eye Disease Study supplements?. Br J Ophthalmol 2009, 93(9):1241-1246.
17. Chiu C.J., Milton R.C., Klein R., et al. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 2009, 116(5):939-946.
18. Cho E., Hung S., Willett W.C., et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001, 73(2):209-218.
19. Chong E.W., Kreis A.J., Wong T.Y., et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008, 126(6):826-833.
20. Chong E.W., Robman L.D., Simpson J.A., et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009, 127(5):674-680.
21. Chua B., Flood V., Rochtchina E., et al. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol 2006, 124(7):981-986.
22. Chuo J.Y., Wiens M., Etminan M., et al. Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies. Ophthalmic Epidemiol 2007, 14(6):367-374.
23. Connor K.M., SanGiovanni J.P., Lofqvist C., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007, 13(7):868-873.
24. Cousins S.W., Espinosa-Heidmann D.G., Alexandridou A., et al. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp Eye Res 2002, 75(5):543-553.
25. Crabb J.W., Miyagi M., Gu X., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002, 99(23):14682-14687.
26. Curcio C.A., Johnson M., Huang J.D., et al. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 2009, 28(6):393-422.
27. Curcio C.A., Johnson M., Huang J.D., et al. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 2009, 28(6):393-422.
28. de Jong P.T. Age-related macular degeneration. N Engl J Med 2006, 355(14):1474-1485.
29. Delcourt C., Carriere I., Cristol J.P., et al. Dietary fat and the risk of age-related maculopathy: the POLANUT study. Eur J Clin Nutr 2007, 61(11):1341-1344.
30. Delcourt C., Michel F., Colvez A., et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 2001, 8(4):237-249.
31. Dithmar S., Sharara N.A., Curcio C.A., et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 2001, 119(11):1643-1649.
32. Donoso L.A., Vrabec T., Kuivaniemi H. The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol 2010, 55(3):227-246.
33. Duncan K.G., Bailey K.R., Kane J.P., et al. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem Biophys Res Commun 2002, 292(4):1017-1022.
34. Duncan K.G., Bailey K.R., Yang H., et al. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol 2009, 93(8):1116-1120.
35. Edwards A.O., Ritter R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308(5720):421-424.
36. Espinosa-Heidmann D.G., Sall J., Hernandez E.P., et al. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 2004, 45(1):260-266.
37. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11(1):81-128.
38. Evereklioglu C., Doganay S., Er H., et al. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: a preliminary study. Eye (Lond) 2003, 17(3):350-355.
39. Fliesler S.J., Anderson R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983, 22(2):79-131.
40. Fliesler S.J., Schroepfer G.J. Sterol composition of bovine retinal rod outer segment membranes and whole retinas. Biochim Biophys Acta 1982, 711(1):138-148.
41. Friedman D.S., O'Colmain B.J., Munoz B., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004, 122(4):564-572.
42. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol 1997, 124(5):677-682.
43. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 2000, 130(5):658-663.
44. Fritsche L.G., Freitag-Wolf S., Bettecken T., et al. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum Mutat 2009, 30(7):1048-1053.
45. Fujihara M., Bartels E., Nielsen L.B., et al. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp Eye Res 2009, 88(6):1115-1123.
46. Fukuzumi K. Relationship between lipoperoxides and diseases. J Environ Pathol Toxicol Oncol 1986, 6(3-4):25-56.
47. Gehlbach P., Li T., Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev. [Review] 2009 Jul 8, (3).
48. Goldberg J., Flowerdew G., Smith E., et al. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988, 128(4):700-710.
49. Gounopoulos P., Merki E., Hansen L.F., et al. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease. Minerva Cardioangiol 2007, 55(6):821-837.
50. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119(10):1417-1436. Group A-REDSR.
51. Gu X., Meer S.G., Miyagi M., et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003, 278(43):42027-42035.
52. Guymer R.H., Chiu A.W., Lim L., et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?. Surv Ophthalmol 2005, 50(2):194-206.
53. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308(5720):419-421.
54. Hall N.F., Gale C.R., Syddall H., et al. Risk of macular degeneration in users of statins: cross sectional study. BMJ 2001, 323(7309):375-376.
55. He K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--eat fish or take fish oil supplement?. Prog Cardiovasc Dis 2009, 52(2):95-114.
56. Heuberger R.A., Mares-Perlman J.A., Klein R., et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 2001, 119(12):1833-1838.
57. Hodge W.G., Schachter H.M., Barnes D., et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006, 113(7):1165-1172.
58. Hollyfield J.G., Bonilha V.L., Rayborn M.E., et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008, 14(2):194-198.
59. Holz F.G., Pauleikhoff D., Bird A.C. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994, 112(3):402-406.
60. Hu F.B., Stampfer M.J., Manson J.E., et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491-1499.
61. Hyman L., Schachat A.P., He Q. , et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000, 118(3):351-358.
62. Hyman L.G., Lilienfeld A.M., Ferris F.L., et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983, 118(2):213-227.
63. Innis S.M. Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?. J Pediatr Gastroenterol Nutr 2009, 48(Suppl 1):S16-S24.
64. Ishida B.Y., Duncan K.G., Chalkley R.J., et al. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 2005, 45(2):263-271.
65. Ishida B.Y., Bailey K.R., Kane J.P., et al. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br J Ophthalmol 2006, 90(5):616-620.
66. Johnson L.V., Ozaki S., Staples M.K., et al. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000, 70(4):441-449.
67. Kaemmerer E., Schutt F., Krohne T.U., et al. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci 2007, 48(3):1342-1347.
68. Kang J.X., Wang J., Wu L., et al. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427(6974):504.
69. Klein R., Deng Y., Klein B.E., et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 2007, 143(3):473-483.
70. Klein R., Klein B.E., Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1993, 100(3):406-414.
71. Klein R., Klein B.E., Tomany S.C., et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003, 110(6):1273-1280.
72. Klein R., Klein B.E., Tomany S.C., et al. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 2003, 121(8):1151-1155.
73. Klein R., Knudtson M.D., Klein B.E. Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 2007, 144(1):1-6.
74. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720):385-389.
75. Kliffen M., Lutgens E., Daemen M.J., et al. The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol 2000, 84(12):1415-1419.
76. Kotani S., Sakaguchi E., Warashina S., et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 2006, 56(2):159-164.
77. Koto T., Nagai N., Mochimaru H., et al. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 2007, 48(9):4328-4334.
78. Krohne T.U., Holz F.G., Kopitz J. Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2010, 51(1):553-560.
79. Lavie C.J., Milani R.V., Mehra M.R., et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54(7):585-594.
80. Li C.M., Zhang X., Dashti N., et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J Lipid Res 2005, 46(4):628-640.
81. Li F., Marchette L.D., Brush R.S., et al. DHA does not protect ELOVL4 transgenic mice from retinal degeneration. Mol Vis 2009, 15:1185-1193.
82. Ludman A., Venugopal V., Yellon D.M., et al. Statins and cardioprotection--more than just lipid lowering?. Pharmacol Ther 2009, 122(1):30-43.
83. MacDonald I.M., Hebert M., Yau R.J., et al. Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy. Br J Ophthalmol 2004, 88(2):305-306.
84. Malek G., Johnson L.V., Mace B.E., et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA 2005, 102(33):11900-11905.
85. Malek G., Guidry C., Medeiros N.E., et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 2003, 162(2):413-425.
86. Mares-Perlman J.A., Brady W.E., Klein R., et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995, 113(6):743-748.
87. Martini E., Scorolli L., Burgagni M.S., et al. Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile. Annali Di Ottalmologia e Clinica Oculistica 1991, 117(11):1121-1126.
88. McCarty C.A., Mukesh B.N., Fu C.L., et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001, 119(10):1455-1462.
89. McCarty C.A., Mukesh B.N., Guymer R.H., et al. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust 2001, 175(6):340.
90. McGwin G., Modjarrad K., Hall T.A., et al. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch Ophthalmol 2006, 124(1):33-37.
91. McGwin G., Owsley C., Curcio C.A., et al. The association between statin use and age related maculopathy. Br J Ophthalmol 2003, 87(9):1121-1125.
92. McGwin G., Xie A., Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 2005, 112(3):488-494.
93. Miceli M.V., Newsome D.A., Tate D.J., et al. Pathologic changes in the retinal pigment epithelium and Bruch's membrane of fat-fed atherogenic mice. Curr Eye Res 2000, 20(1):8-16.
94. Montecucco F., Mach F. Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol 2009, 31(1):127-142.
95. Moore D.J., Clover G.M. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci 2001, 42(12):2970-2975.
96. Mukherjee P.K., Marcheselli V.L., Barreiro S., et al. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc Natl Acad Sci USA 2007, 104(32):13152-13157.
97. Mukherjee P.K., Marcheselli V.L., de Rivero Vaccari J.C., et al. Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc Natl Acad Sci USA 2007, 104(32):13158-13163.
98. Neale B.M., Fagerness J., Reynolds R., et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010, 107(16):7395-7400.
99. Neuringer M., Connor W.E., Lin D.S., et al. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986, 83(11):4021-4025.
100. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003, 290(17):2292-2300.
101. Ong J.M., Zorapapel N.C., Aoki A.M., et al. Impaired electroretinogram (ERG) response in apolipoprotein E-deficient mice. Curr Eye Res 2003, 27(1):15-24.
102. Parker G., Gibson N.A., Brotchie H., et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006, 163(6):969-978.
103. Pawlosky R.J., Denkins Y., Ward G., et al. Retinal and brain accretion of long-chain polyunsaturated fatty acids in developing felines: the effects of corn oil-based maternal diets. Am J Clin Nutr 1997, 65(2):465-472.
104. Polit L., Rotstein N., Carri N. Effects of docosahexaenoic acid on retinal development: cellular and molecular aspects. Lipids 2001, 36(9):927-935.
105. Politi L.E., Rotstein N.P., Carri N.G. Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2001, 42(12):3008-3015.
106. Provost A.C., Vede L., Bigot K., et al. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. Invest Ophthalmol Vis Sci 2009, 50(8):3931-3942.
107. Riediger N.D., Othman R.A., Suh M., et al. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009, 109(4):668-679.
108. Rotstein N.P., Aveldano M.I., Barrantes F.J., et al. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem 1996, 66(5):1851-1859.
109. Rotstein N.P., Aveldano M.I., Barrantes F.J., et al. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 1997, 69(2):504-513.
110. Rudolf M., Winkler B., Aherrahou Z., et al. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol 2005, 89(12):1627-1630.
111. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77(6):937-946.
112. Sangiovanni J.P., Agron E., Meleth A.D., et al. {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: a prospective cohort study from the Age-related Eye Disease Study. Am J Clin Nutr 2009, 90(6):1601-1607.
113. SanGiovanni J.P., Chew E.Y., Agron E., et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008, 126(9):1274-1279.
114. SanGiovanni J.P., Chew E.Y., Clemons T.E., et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007, 125(5):671-679.
115. SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005, 24(1):87-138.
116. Scholl H.P., Fleckenstein M., Charbel Issa P., et al. An update on the genetics of age-related macular degeneration. Mol Vis 2007, 13:196-205.
117. Seddon J.M., Cote J., Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003, 121(12):1728-1737.
118. Seddon J.M., Gensler G., Milton R.C., et al. Association between C-reactive protein and age-related macular degeneration. JAMA 2004, 291(6):704-710.
119. Seddon J.M., George S., Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-related Macular Degeneration. Arch Ophthalmol 2006, 124(7):995-1001.
120. Seddon J.M., Rosner B., Sperduto R.D., et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001, 119(8):1191-1199.
121. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56(8):365-379.
122. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006, 60(9):502-507.
123. Smeeth L., Cook C., Chakravarthy U., et al. A case control study of age related macular degeneration and use of statins. Br J Ophthalmol 2005, 89(9):1171-1175.
124. Smeeth L., Douglas I., Hall A.J., et al. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 2009, 67(1):99-109.
125. Smith W., Mitchell P., Leeder S.R. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 2000, 118(3):401-404.
126. Snow K.K., Seddon J.M. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthalmic Epidemiol 1999, 6(2):125-143.
127. Suh M., Sauve Y., Merrells K.J., et al. Supranormal electroretinogram in fat-1 mice with retinas enriched in docosahexaenoic acid and n-3 very long chain fatty acids (C24-C36). Invest Ophthalmol Vis Sci 2009, 50(9):4394-4401.
128. Suh M., Wierzbicki A.A., Lien E.L., et al. Dietary 20:4n-6 and 22:6n-3 modulates the profile of long- and very-long-chain fatty acids, rhodopsin content, and kinetics in developing photoreceptor cells. Pediatr Res 2000, 48(4):524-530.
129. Tachikawa M., Okayasu S., Hosoya K. Functional involvement of scavenger receptor class B, type I, in the uptake of alpha-tocopherol using cultured rat retinal capillary endothelial cells. Mol Vis 2007, 13:2041-2047.
130. Tan J.S., Mitchell P., Rochtchina E., et al. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol 2007, 143(4):685-687.
131. Tan J.S., Wang J.J., Flood V., et al. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 2009, 127(5):656-665.
132. Tanito M., Brush R.S., Elliott M.H., et al. High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res 2009, 50(5):807-819.
133. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-control Study Group. Arch Ophthalmol 1992, 110(12):1701-1708. TEDC-CS G.
134. Thornton J., Edwards R., Mitchell P., et al. Smoking and age-related macular degeneration: a review of association. Eye (Lond) 2005, 19(9):935-944.
135. Tomany S.C., Wang J.J., Van Leeuwen R., et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004, 111(7):1280-1287.
136. Tuo J., Ross R.J., Herzlich A.A., et al. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol 2009, 175(2):799-807.
137. van Leeuwen R., Boekhoorn S., Vingerling J.R., et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005, 294(24):3101-3107.
138. van Leeuwen R., Ikram M.K., Vingerling J.R., et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003, 44(9):3771-3777.
139. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. Cholesterol and age-related macular degeneration: is there a link?. Am J Ophthalmol 2004, 137(4):750-752.
140. van Leeuwen R., Tomany S.C., Wang J.J., et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 2004, 111(6):1169-1175.
141. Verhoeff F.H., Grossman H.P. The Pathogenesis of Disciform Degeneration of the Macula. Trans Am Ophthalmol Soc 1937, 35:262-294.
142. Vidaurri J.S., Pe'er J., Halfon S.T., et al. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica 1984, 188(4):243-247.
143. Vingerling J.R., Dielemans I., Bots M.L., et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995 Aug 15, 142(4):404-409.
144. Wang L., Li C.M., Rudolf M., et al. Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci 2009, 50(2):870-877.
145. Watts G.F. Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities. Curr Control Trials Cardiovasc Med 2001, 2(3):118-122.
146. Webers C.A., Beckers H.J., Nuijts R.M., et al. Pharmacological management of primary open-angle glaucoma: second-line options and beyond. Drugs Aging 2008, 25(9):729-759.
147. Wiegand R.D., Giusto N.M., Rapp L.M., et al. Evidence for rod outer segment lipid peroxidation following constant illumination of the rat retina. Invest Ophthalmol Vis Sci 1983, 24(10):1433-1435.
148. Wilson H.L., Schwartz D.M., Bhatt H.R., et al. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004, 137(4):615-624.